• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/14

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

14 Cards in this Set

  • Front
  • Back
Insulinogouges
Osu
Repaglinide
Exenatide
Sitagliptin
OSU MoA:
K+ channel blocker= Membrane depolarization= calcium influx= insulin release
INCREASES INSULIN RECEPTOR SENSITIVITY
Acetohexamide Usage
Decrease dose in renal dysfunction
Glipizide
Decrease dose in hepatic dysfunction
Glyburide
Decrease dose in renal dysfunction
OSU SE:
Early morning hypoglycemia( 2-3 AM)
Weight gain
Drug Interaction-Increased Hypoglycemia with cimetidine, insulin, salicylates and sulphonamides-All protein bound
Metformin MoA
Increased tissue sensitivity to insulin and decreased hepatic gluconeogenesis
synergistic with OSU's
Miglitol
Acarbose MoA and SE
Inhibits a-glucosidase in brush borders of small intestine=decreased glucose absorption
Miglitol
Acarbose SE
No hypoglycemia, Heptatotoxicity, flatulence. diarrhea
Pioglitazone and Rosiglitazone MoA and SE
Activates peroxisome proliferator- activating receptors, increases insulin sensitivity and decreases hepatic gluconeogenesis
Exenatide MoA
GLP-1 Receptor agonist(insulinogogue)
Sitagliptin MoA
Inhibits dipeptidyl peptidase-4 thereby inhibiting inactivation of GLP-1( Insulinogogue)
Pramlintide MoA
Synthetic version of amylin slows down the rate at which food is absorbed from the intestine, decreses apetite

Used in DM T1 and T2
Minoxidil and Diazoxite MoA
Open ATP dependent K+ Channels MoA opposite of OSU's
Decreases insulin release